Development of a rapid lateral flow assay for detection of anti-coccidioidal antibodies
Journal of Clinical Microbiology · 21.09.2023 · 61 (9)
DOI: 10.1128/jcm.00631-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Microbiology, erschienen am 21.09.2023. Verfasst von Francisca J Grill und 16 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Arizona State University , Tempe, Arizona, USA. Hauptthemen laut MEDLINE: Biological Assay, Coccidioidomycosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, HHS | National Institutes of Health.
Abstract (Originalsprache)
Coccidioides spp. are dimorphic fungi that are capable of infecting human and non-human mammals and can cause diverse manifestations of coccidioidomycosis or Valley fever (VF). In combination with clinical symptoms and radiographic findings, antibody-based diagnostic tests are often used to diagnose and monitor patients with VF. Chitinase 1 (CTS1) has previously been identified as the seroreactive antigen used in these diagnostic assays to detect anticoccidial IgG. Here, an indirect enzyme-linked immunosorbent assay to detect IgG to CTS1 demonstrated 165 of 178 (92.7%) patients with a positive result by immunodiffusion (ID) and/or complement fixation (CF) had antibodies to the single antigen CTS1. We then developed a rapid antibody lateral flow assay (LFA) to detect anti-CTS1 antibodies. Out of 143 samples tested, the LFA showed 92.9% positive percent agreement [95% confidence interval (CI), 84.3%–96.9%] and 97.7% negative percent agreement (95% CI, 87.9%–99.6%) with ID and CF assays. Serum or plasma from canines, macaques, and dolphins was also tested by the CTS1 LFA. Test line densities of the CTS1 LFA correlated in a linear manner with the reported CF and ID titers for human and non-human samples, respectively. This 10-min point-of-care test for the rapid detection of anti-coccidioidal antibodies could help to inform healthcare providers in real-time, potentially improving the efficiency of healthcare delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Arizona State University , Tempe, Arizona, USA.
- Glycodots LLC , San Diego, California, USA.
- Department of Laboratory Medicine and Pathology, Mayo Clinic , Phoenix, Arizona, USA.
- Division of Infectious Diseases, Mayo Clinic , Phoenix, Arizona, USA.
- Veterinary Neurological Center , Phoenix, Arizona, USA.
- Washington National Primate Research Center , Seattle, Washington, USA.
ORCID-Profile: Thomas E Grys, Douglas F Lake
Förderung
- NIAID NIH HHS
- NIH HHS
- HHS | National Institutes of Health
Zitieren
APA
Grill, F. J., Svarovsky, S., Gonzalez-Moa, M., Kaleta, E., Blair, J. E., Lovato, L., Grant, R., Ross, K., Linnehan, B. K., Meegan, J., Reilly, K. S., Brown, A., Williams, S., Chung, Y., Magee, D. M., Grys, T. E., & Lake, D. F. (2023). Development of a rapid lateral flow assay for detection of anti-coccidioidal antibodies. Journal of Clinical Microbiology, 61(9). https://doi.org/10.1128/jcm.00631-23
Vancouver
Grill FJ, Svarovsky S, Gonzalez-Moa M, Kaleta E, Blair JE, Lovato L, et al. Development of a rapid lateral flow assay for detection of anti-coccidioidal antibodies. Journal of Clinical Microbiology. 2023;61(9). doi:10.1128/jcm.00631-23
BibTeX
@article{Grill2023,
author = {Grill, Francisca J and Svarovsky, Sergei and Gonzalez-Moa, Maria and Kaleta, Erin and Blair, Janis E and Lovato, Lydia and Grant, Richard and Ross, Kyle and Linnehan, Barbara K and Meegan, Jenny and Reilly, Kenta S and Brown, Ashlyn and Williams, Stacy and Chung, Yunro and Magee, D Mitchell and Grys, Thomas E and Lake, Douglas F},
title = {Development of a rapid lateral flow assay for detection of anti-coccidioidal antibodies},
journal = {Journal of Clinical Microbiology},
year = {2023},
volume = {61},
number = {9},
doi = {10.1128/jcm.00631-23}
}
EUVIMED